Sai Life Sciences Approves Q2 FY27 Unaudited Financial Results

Sai Life Sciences Ltd announced the outcome of its Board Meeting held on November 5, 2026. The Board approved the unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2026, along with the limited review reports. Additionally, the Board approved the appointment of three individuals to Senior Management Personnel (SMP) roles, effective November 5, 2026: Mr. Sidhartha Das as Senior Vice President & Head - Human Resources, Mr. Vijay Kumar Suthari as Vice President - Head Quality & Regulatory Affairs, and Mr. Sriram Gopalakrishnan as Senior Vice President - Corporate Communications. The company also announced the allotment of 27,005 and 81,000 equity shares under its ESOP 2008 and MESOP 2018 plans, respectively, leading to an increase in the issued, subscribed, and paid-up equity share capital.